Supplementary table II. Pemphigus vulgaris and pemphigus foliaceus. Adverse events in 24 pemphigus patients treated with rituximab
Published: 9 February 2026| Version 1 | DOI: 10.17632/f36p74z28h.1
Contributor:
Pokphazz ChristjaroonDescription
Adverse events are grouped into infusion-related and serious adverse events. Values represent number of patients (% of total cohort, N=24). Events not observed are listed for completeness.
Files
Institutions
- UNSW SydneyNew South Wales, Sydney
Categories
Rituximab, Pemphigus, Pemphigus (Skin Disease)